Navellier & Associates Inc. Sells 21,976 Shares of Ultralife Co. (NASDAQ:ULBI)

Navellier & Associates Inc. lessened its holdings in Ultralife Co. (NASDAQ:ULBI) by 40.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,345 shares of the technology company’s stock after selling 21,976 shares during the quarter. Navellier & Associates Inc. owned 0.19% of Ultralife worth $292,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in ULBI. Dimensional Fund Advisors LP lifted its position in shares of Ultralife by 5.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,024,491 shares of the technology company’s stock valued at $10,880,000 after buying an additional 51,399 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Ultralife by 203.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 39,111 shares of the technology company’s stock valued at $415,000 after buying an additional 26,206 shares during the last quarter. XTX Topco Ltd lifted its holdings in Ultralife by 192.1% during the 2nd quarter. XTX Topco Ltd now owns 37,399 shares of the technology company’s stock worth $397,000 after purchasing an additional 24,595 shares in the last quarter. Quadrature Capital Ltd purchased a new stake in Ultralife during the 1st quarter worth about $200,000. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Ultralife by 15.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 157,330 shares of the technology company’s stock worth $1,422,000 after purchasing an additional 21,140 shares in the last quarter. Hedge funds and other institutional investors own 30.68% of the company’s stock.

Ultralife Stock Performance

NASDAQ:ULBI opened at $7.63 on Friday. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The stock has a market cap of $126.89 million, a P/E ratio of 13.87 and a beta of 0.98. The business’s 50-day moving average price is $8.81 and its two-hundred day moving average price is $10.12. Ultralife Co. has a twelve month low of $6.36 and a twelve month high of $13.39.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Benchmark reissued a “buy” rating and set a $14.00 price objective on shares of Ultralife in a report on Friday, November 15th. StockNews.com cut Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.